Germany’s health minister Jens Spahn announced on Thursday that his country would engage in discussions with Russia for an eventual purchase of the Sputnik V coronavirus vaccine.
The vaccine is currently under rolling review by the European Medicines Agency (EMA).
“I explained on behalf of Germany to the Council of Health Ministers of the EU, that we would discuss bilaterally with Russia, first of all to know when and what quantities could be delivered,” the minister told the regional radio station WDR.
The Russian coronavirus vaccine is already registered in 59 countries but has not yet received the green light from the European Medicines Agency.
The vaccine is 91.6% effective, according to the Phase III clinical trial results published in the Lancet.
Spahn’s announcement comes after the German state of Bavaria negotiated a “preliminary contract” to receive 2.5 million doses of the Russian COVID-19 vaccine Sputnik V, according to the regional leader.
The EU’s vaccination rollout has been criticised for being too slow and some member states have said they would potentially purchase the Russian vaccine.
Currently, Hungary is the only EU member state administering the vaccine.
This story is currently being updated by our journalists.